TAZ anticorps (N-Term, pSer89)
Aperçu rapide pour TAZ anticorps (N-Term, pSer89) (ABIN4889551)
Antigène
Voir toutes TAZ AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term, pSer89
-
Specificité
- Reacts with human TAZ pS89 protein
-
Réactivité croisée
- Souris, Rat (Rattus)
-
Réactivité croisée (Details)
- Cross reacts with protein from mouse, rat and other specied due to sequence homologie.
-
Purification
- Purified (protein A)
-
Immunogène
- Synthetic peptide derived from N-term part of the human TAZ protein containing a phosphoserine at position 89
-
-
-
-
Indications d'application
-
Working dilution: Optimal dilutions should be determined by the end user.
The following are guidelines only:
WB1:500 - 1:5 000 IF1:200 - 1:1000 -
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Must be reconstituted in distilled water.
-
Concentration
- 1 mg/mL
-
Buffer
- Tris 0,1M, glycine 0,1M, sucrose 2 %
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt.
-
Date de péremption
- 24 months
-
-
- TAZ (Tafazzin (TAZ))
-
Autre désignation
- TAZ
-
Sujet
- Transcriptional coactivator which acts as a downstream regulatory target in the Hippo signaling pathway that plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis.
-
UniProt
- Q9GZV5
Antigène
-